“Preservative Toxicity a Disease,” Reports Working Group on Glaucoma Medication Preservatives Toxicity

Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC, announced that the Working Group on Preservatives Toxicity in Glaucoma Medications, an advisory panel of glaucoma treatment experts, was recently convened as an ongoing group to examine the issue of preservatives in glaucoma medications from an evidence-based perspective. The Working Group is sponsored by Valeant Ophthalmics. At its first roundtable, the Working Group discussed the interface between ocular surface dise...

Full Story →